2024
article
OpenAlex
Ran Orgad, Naoual Bakrin, Isabelle Bonnefoy, Laurent Villeneuve et autres
OBJECTIVE: To analyze the reasons for stopping pressurized intraperitoneal aerosolized chemotherapy (PIPAC) delivered for unresectable peritoneal surface malignancies (PSMs) and to determine survival in a large patient cohort of an experienced PIPAC center. BACKGROUND: PIPAC alone or combined with systemic chemotherapy was …
fr, sa
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Alexis Trécourt, Naoual Bakrin, Olivier Gléhen, Witold Gertych et autres
BACKGROUND: Ovarian pseudomyxoma peritonei (OPMP) are rare, without well-defined therapeutic guidelines. We aimed to evaluate cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) to treat OPMP. METHODS: Patients from the French National Network for Rare Peritoneal Tumors (RENAPE) database with proven OPMP …
fr, kw
(code pays fourni par la source)
2024
article
OpenAlex
Alexis Trécourt, Naoual Bakrin, Olivier Gléhen, Witold Gertych et autres
fr, kw
(code pays fourni par la source)
2023
article
OpenAlex
Frédéric Schell, Amaniel Kefleyesus, Nazim Benzerdjeb, Guillaume Passot et autres
fr, ch
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Vahan Képénékian, Amaniel Kefleyesus, David Keskin, Nazim Benzerdjeb et autres
Pseudomyxoma peritonei (PMP) is ideally treated by cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC), leading to significant morbidity. Beyond the histologic grade, the prognosis lies in the completeness of cytoreduction (CC-score of 0/1 vs. 2/3) and the severe complication rate. The …
fr, ch
(code pays fourni par la source)